{"id":243902,"date":"2026-09-11T13:00:04","date_gmt":"2026-09-11T07:30:04","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/tata-nifty-midsmall-healthcare-index-fund-direct-growth-review-2026\/"},"modified":"2026-09-11T13:00:04","modified_gmt":"2026-09-11T07:30:04","slug":"tata-nifty-midsmall-healthcare-index-fund-direct-growth-review-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/tata-nifty-midsmall-healthcare-index-fund-direct-growth-review-2026\/","title":{"rendered":"Tata Nifty MidSmall Healthcare Index Fund Direct Growth Review 2026: NAV, Returns, Portfolio &#038; Should You Invest?"},"content":{"rendered":"<p><a href=\"https:\/\/univest.in\/mutual-funds\/tata-nifty-midsmall-healthcare-index-fund-g-direct-plan\">Tata Nifty MidSmall Healthcare Index Fund Direct Growth Plan<\/a> had a NAV of \u20b915.3587 as of 10 September 2026 and an AUM of \u20b9219 Cr. Its 1-year, 3-year and 5-year returns are 17.95%, 0% and 0%, respectively, and it sits in the High Risk category. In our view, it suits investors who can tolerate sharp swings and want a focused healthcare theme, but the short history means the longer-term return record is still too limited to judge with confidence.<\/p>\n<p>The fund\u2019s launch in April 2024 makes the recent record more relevant than any long-term outcome. The portfolio is concentrated in healthcare names and the fund is designed to track a theme rather than a broad market basket, so the return pattern may differ from the wider market in meaningful ways.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/tata-nifty-midsmall-healthcare-index-fund-direct-growth-review-2026\/#Quick_facts\" title=\"Quick facts\">Quick facts<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/tata-nifty-midsmall-healthcare-index-fund-direct-growth-review-2026\/#Performance\" title=\"Performance\">Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/tata-nifty-midsmall-healthcare-index-fund-direct-growth-review-2026\/#Should_you_BUY_or_HOLD_Tata_Nifty_MidSmall_Healthcare_Index\" title=\"Should you BUY or HOLD Tata Nifty MidSmall Healthcare Index?\">Should you BUY or HOLD Tata Nifty MidSmall Healthcare Index?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/tata-nifty-midsmall-healthcare-index-fund-direct-growth-review-2026\/#Peer_comparison\" title=\"Peer comparison\">Peer comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/tata-nifty-midsmall-healthcare-index-fund-direct-growth-review-2026\/#Portfolio_where_your_money_goes\" title=\"Portfolio: where your money goes\">Portfolio: where your money goes<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/tata-nifty-midsmall-healthcare-index-fund-direct-growth-review-2026\/#Who_should_invest\" title=\"Who should invest\">Who should invest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/tata-nifty-midsmall-healthcare-index-fund-direct-growth-review-2026\/#Tax_and_exit_load\" title=\"Tax and exit load\">Tax and exit load<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/tata-nifty-midsmall-healthcare-index-fund-direct-growth-review-2026\/#Frequently_asked_questions\" title=\"Frequently asked questions\">Frequently asked questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/tata-nifty-midsmall-healthcare-index-fund-direct-growth-review-2026\/#What_is_the_current_NAV_of_Tata_Nifty_MidSmall_Healthcare_Index_Fund_Direct_Growth_Plan\" title=\"What is the current NAV of Tata Nifty MidSmall Healthcare Index Fund Direct Growth Plan?\">What is the current NAV of Tata Nifty MidSmall Healthcare Index Fund Direct Growth Plan?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/tata-nifty-midsmall-healthcare-index-fund-direct-growth-review-2026\/#What_are_the_funds_1-year_3-year_and_5-year_returns\" title=\"What are the fund\u2019s 1-year, 3-year and 5-year returns?\">What are the fund\u2019s 1-year, 3-year and 5-year returns?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/tata-nifty-midsmall-healthcare-index-fund-direct-growth-review-2026\/#How_has_the_fund_performed_versus_its_benchmark\" title=\"How has the fund performed versus its benchmark?\">How has the fund performed versus its benchmark?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/tata-nifty-midsmall-healthcare-index-fund-direct-growth-review-2026\/#How_does_it_compare_with_the_peer_funds_shown_here\" title=\"How does it compare with the peer funds shown here?\">How does it compare with the peer funds shown here?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/tata-nifty-midsmall-healthcare-index-fund-direct-growth-review-2026\/#What_is_the_minimum_SIP_amount\" title=\"What is the minimum SIP amount?\">What is the minimum SIP amount?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/tata-nifty-midsmall-healthcare-index-fund-direct-growth-review-2026\/#What_are_the_funds_risk_level_key_holdings_and_exit_load\" title=\"What are the fund\u2019s risk level, key holdings and exit load?\">What are the fund\u2019s risk level, key holdings and exit load?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/tata-nifty-midsmall-healthcare-index-fund-direct-growth-review-2026\/#Bottom_line\" title=\"Bottom line\">Bottom line<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/tata-nifty-midsmall-healthcare-index-fund-direct-growth-review-2026\/#Explore_mutual_funds_with_Univest\" title=\"Explore mutual funds with Univest\">Explore mutual funds with Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/tata-nifty-midsmall-healthcare-index-fund-direct-growth-review-2026\/#RIA_disclosure\" title=\"RIA disclosure\">RIA disclosure<\/a><\/li><\/ul><\/nav><\/div>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Quick_facts\"><\/span>Quick facts<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Particular<\/th>\n<th>Details<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>NAV<\/td>\n<td>\u20b915.3587 as of 10 Sep 2026<\/td>\n<\/tr>\n<tr>\n<td>AUM<\/td>\n<td>\u20b9219 Cr<\/td>\n<\/tr>\n<tr>\n<td>Expense Ratio<\/td>\n<td>0.5%<\/td>\n<\/tr>\n<tr>\n<td>Launch Date<\/td>\n<td>26 Apr 2024<\/td>\n<\/tr>\n<tr>\n<td>Min SIP<\/td>\n<td>\u20b9100<\/td>\n<\/tr>\n<tr>\n<td>Risk Category<\/td>\n<td>High Risk<\/td>\n<\/tr>\n<tr>\n<td>Benchmark<\/td>\n<td>Nifty 50<\/td>\n<\/tr>\n<tr>\n<td>Fund Category<\/td>\n<td>Index Funds<\/td>\n<\/tr>\n<tr>\n<td>Exit Load<\/td>\n<td>0.25% on or before 15D, Nil after 15D<\/td>\n<\/tr>\n<tr>\n<td>Fund Managers<\/td>\n<td>Nitin Sharma, Rakesh Prajapati<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The fund is managed by Nitin Sharma and Rakesh Prajapati.<\/p>\n<p class=\"mf-source-date\"><small>Source data date: as of 10 Sep 2026<\/small><\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Performance\"><\/span>Performance<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Period<\/th>\n<th>Fund return<\/th>\n<th>Benchmark return<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1M<\/td>\n<td>-0.71%<\/td>\n<td>-4.06%<\/td>\n<\/tr>\n<tr>\n<td>3M<\/td>\n<td>9%<\/td>\n<td>1.37%<\/td>\n<\/tr>\n<tr>\n<td>1Y<\/td>\n<td>17.95%<\/td>\n<td>-7.31%<\/td>\n<\/tr>\n<tr>\n<td>3Y<\/td>\n<td>Data not available<\/td>\n<td>Data not available<\/td>\n<\/tr>\n<tr>\n<td>5Y<\/td>\n<td>Data not available<\/td>\n<td>Data not available<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Recent performance has been uneven but constructive. The 1-month figure is slightly negative, yet it is still better than the benchmark\u2019s weaker one-month reading. Over 3 months, the fund turned in a stronger gain than the benchmark, which suggests the theme had a better short-run stretch than the wider market.<\/p>\n<p>The 1-year return is the clearest positive signal in the record available today. At 17.95%, it stands well above the benchmark\u2019s -7.31%, which means the fund has materially outpaced the market benchmark over the past year. That gap matters because it shows the healthcare theme has not simply moved with the broad market.<\/p>\n<p>At the same time, the fund\u2019s brief life means there is no 3-year or 5-year trail to study. We therefore place more weight on the 1-year path and the shorter run-up and pullback pattern visible in the performance line. Our view is that the fund has shown meaningful upside in a sector-led phase, but the record is still too new to treat that as a stable long-term pattern.<\/p>\n<p class=\"mf-source-date\"><small>Source data date: as of 10 Sep 2026<\/small><\/p>\n<section class=\"univest-mf-premium-cta\" style=\"margin:28px 0;padding:24px;border-radius:10px;border:1px solid #d8e3f0;background:#f7faff\">\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Should_you_BUY_or_HOLD_Tata_Nifty_MidSmall_Healthcare_Index\"><\/span>Should you BUY or HOLD Tata Nifty MidSmall Healthcare Index?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>A fund&#8217;s past returns alone don&#8217;t tell you whether you should buy it today or continue holding it.<\/p>\n<p>The right decision depends on factors such as your current allocation, purchase price, risk profile, investment horizon and the role this fund plays in your overall portfolio.<\/p>\n<p><strong>Already holding Tata Nifty MidSmall Healthcare Index? Thinking of investing now?<\/strong><\/p>\n<p><a href=\"https:\/\/univest.in\/mutual-funds\" style=\"font-weight:700;text-decoration:none\">Get your portfolio analysed for FREE by SEBI-registered Investment Adviser (RIA) through Univest MF Premium<\/a><\/p>\n<\/section>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Peer_comparison\"><\/span>Peer comparison<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Fund<\/th>\n<th>1Y return<\/th>\n<th>3Y return<\/th>\n<th>5Y return<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><a href=\"https:\/\/univest.in\/mutual-funds\/tata-nifty-midsmall-healthcare-index-fund-g-direct-plan\">Tata Nifty MidSmall Healthcare Index Fund Direct Growth Plan<\/a><\/td>\n<td>17.95%<\/td>\n<td>Data not available<\/td>\n<td>Data not available<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/mutual-funds\/icici-pru-nasdaq-100-index-fund-g-direct-plan\">ICICI Pru NASDAQ 100 Index Fund Direct Growth Plan<\/a><\/td>\n<td>33.08%<\/td>\n<td>30.07%<\/td>\n<td>Data not available<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/mutual-funds\/motilal-oswal-nifty-india-defence-index-fund-g-direct-plan\">Motilal Oswal Nifty India Defence Index Fund Direct Growth Plan<\/a><\/td>\n<td>26.95%<\/td>\n<td>Data not available<\/td>\n<td>Data not available<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/mutual-funds\/aditya-birla-sl-nifty-india-defence-index-fund-g-direct-plan\">Aditya Birla SL Nifty India Defence Index Fund Direct Growth Plan<\/a><\/td>\n<td>26.94%<\/td>\n<td>Data not available<\/td>\n<td>Data not available<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/mutual-funds\/tata-nifty-capital-markets-index-fund-g-direct-plan\">Tata Nifty Capital Markets Index Fund Direct Growth Plan<\/a><\/td>\n<td>24.33%<\/td>\n<td>Data not available<\/td>\n<td>Data not available<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/mutual-funds\/motilal-oswal-nifty-capital-market-index-fund-g-direct-plan\">Motilal Oswal Nifty Capital Market Index Fund Direct Growth Plan<\/a><\/td>\n<td>23.74%<\/td>\n<td>Data not available<\/td>\n<td>Data not available<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>This assessment is prepared by Uniapps Investment Adviser Pvt. Ltd. under SEBI Registered Investment Adviser registration INA000017639.<\/p>\n<p>The fund\u2019s 1-year return is below the leading peer figures shown here, including the two defence-themed index funds and the NASDAQ-100 fund. That does not make the healthcare fund weak on its own terms, but it does show that its recent momentum has been more moderate than several other thematic index strategies over the same horizon.<\/p>\n<p>The longer-term comparison is less informative because the fund has no 3-year or 5-year history yet, while the NASDAQ-100 peer does have a strong 3-year record. So the peer view tells two different stories: recent performance is respectable, but the available longer-history peers have had more time to compound and, in the case of some funds, have done so more strongly.<\/p>\n<p class=\"mf-source-date\"><small>Source data date: as of 10 Sep 2026<\/small><\/p>\n<div class=\"univest-peer-login-cta\" style=\"margin:20px 0;padding:16px 18px;border:1px solid #d8e3f0;border-radius:8px;background:#f7faff\">\n<p style=\"margin:0\"><strong>Want to know more?<\/strong> <a href=\"https:\/\/univest.in\/user\/log-in\" style=\"font-weight:700;text-decoration:none\">Log in to Univest<\/a> for more mutual fund insights.<\/p>\n<\/div>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Portfolio_where_your_money_goes\"><\/span>Portfolio: where your money goes<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Holding<\/th>\n<th>Sector<\/th>\n<th>Weight<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Laurus Labs Ltd<\/td>\n<td>Healthcare<\/td>\n<td>11.22%<\/td>\n<\/tr>\n<tr>\n<td>Lupin Ltd<\/td>\n<td>Healthcare<\/td>\n<td>8.01%<\/td>\n<\/tr>\n<tr>\n<td>Aurobindo Pharma Ltd<\/td>\n<td>Healthcare<\/td>\n<td>7.16%<\/td>\n<\/tr>\n<tr>\n<td>Fortis Healthcare Ltd<\/td>\n<td>Healthcare<\/td>\n<td>7.12%<\/td>\n<\/tr>\n<tr>\n<td>Glenmark Pharmaceuticals Ltd<\/td>\n<td>Healthcare<\/td>\n<td>5.62%<\/td>\n<\/tr>\n<tr>\n<td>Alkem Laboratories Ltd<\/td>\n<td>Healthcare<\/td>\n<td>4.7%<\/td>\n<\/tr>\n<tr>\n<td>Biocon Ltd<\/td>\n<td>Healthcare<\/td>\n<td>4.43%<\/td>\n<\/tr>\n<tr>\n<td>Ipca Laboratories Ltd<\/td>\n<td>Healthcare<\/td>\n<td>4.13%<\/td>\n<\/tr>\n<tr>\n<td>Mankind Pharma Ltd<\/td>\n<td>Healthcare<\/td>\n<td>4.13%<\/td>\n<\/tr>\n<tr>\n<td>Gland Pharma Ltd<\/td>\n<td>Healthcare<\/td>\n<td>3.46%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The top 10 holdings account for approximately 59.98% of the portfolio.<\/p>\n<p>To see all holdings, visit the <a href=\"https:\/\/univest.in\/mutual-funds\/tata-nifty-midsmall-healthcare-index-fund-g-direct-plan\">Tata Nifty MidSmall Healthcare Index Fund Direct Growth Plan<\/a> page<\/p>\n<p>The largest holding, Laurus Labs Ltd, carries a weight of 11.22%, so it may have greater influence on day-to-day movement than the smaller positions below it. The tenth holding, Gland Pharma Ltd, is at 3.46%, which shows that weight does fall away, but not in a straight drop; several mid-sized positions still carry meaningful weight.<\/p>\n<p>With the top 10 positions making up 59.98% of the portfolio and a total of 30 disclosed holdings, the structure looks moderately concentrated rather than fully spread out. That concentration may matter more in a sector fund, because individual stock moves can have a larger effect when the portfolio is built around a narrower theme.<\/p>\n<p>At the same time, the remaining holdings still provide a tail beyond the top names, so the fund is not entirely dependent on one or two stocks. Our view is that the portfolio balance is best described as focused, with enough spread to avoid extreme single-stock dependence but not enough breadth to dilute theme risk meaningfully.<\/p>\n<p class=\"mf-source-date\"><small>Source data date: as of 10 Sep 2026<\/small><\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Who_should_invest\"><\/span>Who should invest<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This fund is better suited to investors who can accept High Risk exposure and who are comfortable with a sector-led return path. The one-year record is encouraging, but the absence of 3-year and 5-year history means the fund has not yet built a long track record through different market cycles.<\/p>\n<p>An investor with a medium to long horizon may find the theme more appropriate than someone looking for steady, broad-market style returns. The main trade-off is clear: the healthcare focus can create stronger moves than a diversified equity fund, so the potential for outperformance comes with a narrower engine and more uneven year-to-year behaviour.<\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Tax_and_exit_load\"><\/span>Tax and exit load<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Holding period<\/th>\n<th>Tax rate<\/th>\n<th>Description<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Units held less than 1 year<\/td>\n<td>20%<\/td>\n<td>Short-term capital gains tax<\/td>\n<\/tr>\n<tr>\n<td>Units held more than 1 year<\/td>\n<td>12.5%<\/td>\n<td>Long-term capital gains tax<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Exit load: 0.25% on or before 15D, Nil after 15D.<\/p>\n<p class=\"mf-source-date\"><small>Source data date: as of 10 Sep 2026<\/small><\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Frequently_asked_questions\"><\/span>Frequently asked questions<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"What_is_the_current_NAV_of_Tata_Nifty_MidSmall_Healthcare_Index_Fund_Direct_Growth_Plan\"><\/span>What is the current NAV of Tata Nifty MidSmall Healthcare Index Fund Direct Growth Plan?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The current NAV is \u20b915.3587 as of 10 September 2026.<\/p>\n<h3 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"What_are_the_funds_1-year_3-year_and_5-year_returns\"><\/span>What are the fund\u2019s 1-year, 3-year and 5-year returns?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Its 1-year return is 17.95%, while the 3-year and 5-year returns are Data not available.<\/p>\n<h3 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"How_has_the_fund_performed_versus_its_benchmark\"><\/span>How has the fund performed versus its benchmark?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Over 1 year, the fund has returned 17.95% versus -7.31% for the benchmark. Over 3 months, it has returned 9% versus 1.37% for the benchmark.<\/p>\n<h3 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"How_does_it_compare_with_the_peer_funds_shown_here\"><\/span>How does it compare with the peer funds shown here?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Its 1-year return of 17.95% is below the peer figures shown for ICICI Pru NASDAQ 100 Index Fund Direct Growth Plan, Motilal Oswal Nifty India Defence Index Fund Direct Growth Plan, Aditya Birla SL Nifty India Defence Index Fund Direct Growth Plan, Tata Nifty Capital Markets Index Fund Direct Growth Plan and Motilal Oswal Nifty Capital Market Index Fund Direct Growth Plan.<\/p>\n<h3 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"What_is_the_minimum_SIP_amount\"><\/span>What is the minimum SIP amount?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The minimum SIP amount is \u20b9100.<\/p>\n<h3 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"What_are_the_funds_risk_level_key_holdings_and_exit_load\"><\/span>What are the fund\u2019s risk level, key holdings and exit load?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The fund is in the High Risk category. Its largest holding is Laurus Labs Ltd at 11.22%, and the exit load is 0.25% on or before 15D, Nil after 15D.<\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Bottom_line\"><\/span>Bottom line<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This fund has shown a better recent return path than its benchmark, but only over a short history, so the longer-term case is still developing. Against the peer set shown here, its one-year return is more modest, yet the comparison is not apples-to-apples because some peers have longer records and different themes. The portfolio is focused on healthcare names and the top 10 holdings make up 59.98% of assets, which supports a concentrated thematic profile for investors who can handle High Risk exposure.<\/p>\n<p class=\"univest-posted-at\" style=\"font-size:14px;color:#666;margin:20px 0 8px\">Published on 11 September 2026 at 12:58 PM IST<\/p>\n<section class=\"univest-login-cta\" style=\"margin:28px 0;padding:24px;border-radius:10px;background:#eef5ff;border:1px solid #cddff7;text-align:center\">\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Explore_mutual_funds_with_Univest\"><\/span>Explore mutual funds with Univest<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Review mutual fund data, compare performance and explore fund insights on Univest.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\" style=\"display:inline-block;padding:11px 20px;border-radius:6px;background:#1f4e79;color:#fff !important;text-decoration:none;font-weight:700\">Explore Univest<\/a><\/p>\n<\/section>\n<section class=\"univest-disclaimer\">\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"RIA_disclosure\"><\/span>RIA disclosure<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Mutual fund investments are subject to market risks. Read all scheme-related documents carefully before investing. This review is prepared by Uniapps Investment Adviser Pvt. Ltd. (earlier known as Uniapps Global Research Pvt. Ltd.) under SEBI Registered Investment Adviser registration INA000017639 for general informational purposes and is not personalized investment advice.<\/p>\n<\/section>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"InvestmentFund\",\"name\":\"Tata Nifty MidSmall Healthcare Index Fund Direct Growth Plan\",\"identifier\":\"tata-nifty-midsmall-healthcare-index-fund-g-direct-plan\",\"category\":\"Index Funds\",\"dateCreated\":\"26 Apr 2024\",\"isAccessibleForFree\":true,\"additionalProperty\":[{\"@type\":\"PropertyValue\",\"name\":\"NAV\",\"value\":15.3587,\"valueReference\":\"as of 10 Sep 2026\"},{\"@type\":\"PropertyValue\",\"name\":\"AUM\",\"value\":\"219 Cr\"},{\"@type\":\"PropertyValue\",\"name\":\"Expense Ratio\",\"value\":\"0.5\"},{\"@type\":\"PropertyValue\",\"name\":\"Benchmark\",\"value\":\"Nifty 50\"},{\"@type\":\"PropertyValue\",\"name\":\"1Y Return\",\"value\":17.95},{\"@type\":\"PropertyValue\",\"name\":\"3Y Return\",\"value\":0},{\"@type\":\"PropertyValue\",\"name\":\"5Y Return\",\"value\":0},{\"@type\":\"PropertyValue\",\"name\":\"Fund Managers\",\"value\":\"Nitin Sharma, Rakesh Prajapati\"}]}<\/script><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the current NAV of Tata Nifty MidSmall Healthcare Index Fund Direct Growth Plan?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The current NAV is \u20b915.3587 as of 10 September 2026.\"}},{\"@type\":\"Question\",\"name\":\"What are the fund\u2019s 1-year, 3-year and 5-year returns?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Its 1-year return is 17.95%, while the 3-year and 5-year returns are Data not available.\"}},{\"@type\":\"Question\",\"name\":\"How has the fund performed versus its benchmark?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Over 1 year, the fund has returned 17.95% versus -7.31% for the benchmark. Over 3 months, it has returned 9% versus 1.37% for the benchmark.\"}},{\"@type\":\"Question\",\"name\":\"How does it compare with the peer funds shown here?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Its 1-year return of 17.95% is below the peer figures shown for ICICI Pru NASDAQ 100 Index Fund Direct Growth Plan, Motilal Oswal Nifty India Defence Index Fund Direct Growth Plan, Aditya Birla SL Nifty India Defence Index Fund Direct Growth Plan, Tata Nifty Capital Markets Index Fund Direct Growth Plan and Motilal Oswal Nifty Capital Market Index Fund Direct Growth Plan.\"}},{\"@type\":\"Question\",\"name\":\"What is the minimum SIP amount?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The minimum SIP amount is \u20b9100.\"}},{\"@type\":\"Question\",\"name\":\"What are the fund\u2019s risk level, key holdings and exit load?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The fund is in the High Risk category. Its largest holding is Laurus Labs Ltd at 11.22%, and the exit load is 0.25% on or before 15D, Nil after 15D.\"}}]}<\/script><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"Organization\",\"name\":\"Uniapps Investment Adviser Pvt. Ltd.\",\"description\":\"SEBI Registered Investment Adviser INA000017639\"}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tata Nifty MidSmall Healthcare Index Fund Direct Growth Plan had a NAV of \u20b915.3587 as of 10 September 2026, an AUM of \u20b9219 Cr and a 1-year return of 17.95%. It is a High Risk healthcare-themed index fund with a concentrated top-holdings profile.<\/p>\n","protected":false},"author":38,"featured_media":243899,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3841],"tags":[],"class_list":["post-243902","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mutual-funds"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["243899"],"rank_math_title":["Tata Nifty MidSmall Healthcare Index Fund Review"],"rank_math_description":["Tata Nifty MidSmall Healthcare Index Fund Direct Growth Plan NAV \u20b915.3587, 1Y return 17.95%. Review, portfolio and risk."],"rank_math_focus_keyword":["Tata Nifty MidSmall Healthcare Index Fund Direct Growth Plan review"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/Tata_Nifty_MidSmall_Healthcare_Index_Fund_Direct_Growth_Review_2026_NAV_Returns_Portfolio_Should_You_Invest_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/243902","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=243902"}],"version-history":[{"count":0,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/243902\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/243899"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=243902"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=243902"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=243902"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}